Gut Bacteria Linked to Future Parkinson's Risk

A groundbreaking study indicates that specific gut bacteria may serve as early indicators for Parkinson's disease, potentially years before motor symptoms emerge. Researchers analyzed gut microbes from individuals in the UK, including those diagnosed with Parkinson's, carriers of a high-risk GBA1 variant, and a healthy control group.

Analysis revealed distinct differences in gut microbial composition among Parkinson's patients. Notably, non-symptomatic GBA1 variant carriers exhibited microbial changes resembling an intermediate stage of the disease, suggesting a gut-first pathology.

Further findings suggested that a more diverse and balanced diet correlates with microbiome patterns less associated with a higher Parkinson's risk. These patterns were consistently observed across participants in the UK, Korea, and Turkey, pointing to universal microbial changes.

Experts emphasize the urgent need for treatments to slow Parkinson's progression, a rapidly growing neurodegenerative disease. The study supports the gut-brain axis theory and paves the way for research into pre-symptomatic interventions to prevent or mitigate future risk, especially with an aging global population.